Htut Win
Cardiovascular Disease · Sugar Land, TXNPI 1013183870
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 87 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Abbott at 27.4% of the total. Reporting peaked in 2022 at $1,579 and has fallen 93.7% since, to $99 in 2024.
Across 87 payments — averaging $48.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$1K
- Medtronic$675
- Boston Scientific$585
- Johnson & Johnson$274
- Biotronik Inc.$240
- Siemens Medical Solutions USA, Inc.$193
- plus $1K from 16 others
What the payments were for
- Food & beverage$4,217100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 22 | $1,156 |
| Medtronic(2 entities) | 6 | $675 |
| Boston Scientific | 7 | $585 |
| Johnson & Johnson | 16 | $274 |
| Biotronik Inc. | 3 | $240 |
| Siemens Medical Solutions USA, Inc. | 2 | $193 |
| Abiomed | 2 | $152 |
| Acutus Medical, Inc. | 1 | $135 |
| Shockwave Medical, Inc | 1 | $124 |
| Angiodynamics, Inc. | 1 | $122 |
| Heartflow, Inc. | 1 | $113 |
| Sanofi-aventis U.S. LLC | 5 | $78 |
| E.r. Squibb & Sons, L.L.C. | 3 | $74 |
| Novartis | 4 | $72 |
| AstraZeneca | 4 | $63 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $30 |
| Althera Pharmaceuticals LLC | 1 | $25 |
| Merck | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $19 |
| Amgen | 1 | $18 |
| Getinge USA Sales, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CARDIOMEMS$606
- Resolute$260
- CoreValve Evolut$239
- Impella$134
- Artis icono floor$126
- AVVIGO Guidance System$126
- SYNERGY$125
- Vascular Lithotripsy$124
- AngioVac$122
- RESOLUTE ONYX$116
- Xience Sierra Coronary Stent$114
- FFRct$113
- FFR LINK$109
- COMET$104
How this compares
$4,217 in reported general payments places this provider in the 55th percentile of 1,515 cardiovascular disease providers in Texas.
Other cardiovascular disease in Sugar Land
- George MillerSugar Land$168K
- Byron EllisSugar Land$118K
- Ramin Farzaneh-FarDallas$17.1M
- John OsborneGrapevine$1.3M
- Darren McGuireDallas$1.2M
- Peter McCulloughDallas$664K
- Ann NavarDallas$616K
- Biykem BozkurtHouston$606K
- Milton PackerDallas$530K
- Amarinder BindraDallas$512K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.